Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Deloitte
Fuji
Medtronic
Daiichi Sankyo
Dow
Cantor Fitzgerald
US Army
Covington
Farmers Insurance

Generated: February 21, 2018

DrugPatentWatch Database Preview

Levopropoxyphene napsylate anhydrous - Generic Drug Details

« Back to Dashboard

What are the generic sources for levopropoxyphene napsylate anhydrous and what is the scope of levopropoxyphene napsylate anhydrous freedom to operate?

Levopropoxyphene napsylate anhydrous
is the generic ingredient in one branded drug marketed by Lilly and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for levopropoxyphene napsylate anhydrous
Medical Subject Heading (MeSH) Categories for levopropoxyphene napsylate anhydrous

US Patents and Regulatory Information for levopropoxyphene napsylate anhydrous

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly NOVRAD levopropoxyphene napsylate anhydrous SUSPENSION;ORAL 012928-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly NOVRAD levopropoxyphene napsylate anhydrous CAPSULE;ORAL 012928-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly NOVRAD levopropoxyphene napsylate anhydrous CAPSULE;ORAL 012928-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Cerilliant
Express Scripts
Cantor Fitzgerald
Healthtrust
Citi
Boehringer Ingelheim
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot